Markets:

Overview

News

Currencies

International

Treasuries

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

41.76 -0.39 (-0.93%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vera Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 12, 2023

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.

Via Benzinga

Why Shares of Vera Therapeutics Are Soaring Monday ↗

June 12, 2023

The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.

Via The Motley Fool

US Stocks Open Higher; Nasdaq Rises Over 50 Points ↗

June 12, 2023

U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

7 Stocks That Wall Street Analysts Are Loving in June ↗

June 11, 2023

Sometimes, it’s better to get your ideas from the experts. Thus, if you lack time, these top analyst recommend stocks could be enticing.

Via InvestorPlace

Recap: Vera Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Vera Therapeutics: Here's What You Need To Know ↗

March 29, 2023

Via Benzinga

Why Vera Therapeutics Stock Bolted Higher This Week ↗

January 22, 2023

Vera's stock gained a noteworthy 49% this week.

Via The Motley Fool

What 4 Analyst Ratings Have To Say About Vera Therapeutics ↗

January 04, 2023

Via Benzinga

$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 04, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

$12M Bet On Vera Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

February 09, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 02, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 02, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 01, 2023

Via Benzinga

Vera Therapeutics Releases Interim Analysis Of Rare Kidney Disease Drug, Deprioritizes Certain Phase 3 Programs ↗

January 30, 2023

Vera Therapeutics Inc (NASDAQ: VERA) has announced results from a prespecified per-protocol (PP) analysis of the Phase 2b ORIGIN trial of atacicept in IgA nephropathy (IgAN) patients.

Via Benzinga

5 Cheapest Health Care Stocks You Should Think About ↗

January 13, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Top 5 Health Care Stocks That May Surge ↗

January 10, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Dow Gains 150 Points After Fed Minutes ↗

January 04, 2023

U.S. stocks traded higher toward the end of trading, following the release of minutes from the FOMC meeting.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 05, 2023

On Thursday, 63 companies set new 52-week lows.

Via Benzinga

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 04, 2023

On Wednesday, 35 companies reached new 52-week lows.

Via Benzinga

Nasdaq Rises Over 100 Points; Crude Oil Drops Sharply ↗

January 04, 2023

U.S. stocks extended gains midway through trading, with the Dow Jones gaining around 250 points on Wednesday ahead of the release of minutes from the Fed's meeting.

Via Benzinga

These 2 Nasdaq Biotechs Are Making Big Moves Wednesday ↗

January 04, 2023

The binary nature of biotech investing is making itself obvious from recent study results.

Via The Motley Fool

Why Vera Stock Crashed 60% On Its 'Positive' Kidney Drug Update — And Chinook Popped ↗

January 04, 2023

The "devil is in the details" when it comes to comparing data across studies.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 ↗

January 04, 2023

Via Benzinga

US Stocks Open Higher Ahead Of Fed Minutes; Dow Rises 100 Points ↗

January 04, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

Headline News about Vera Therapeutics, Inc. - Class A Common Stock

Starting at $3.75/week.

Subscribe Today